Federal Register / Vol. 89, No. 194 / Monday, October 7, 2024 / Notices 81109 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

U.S.C. appendix 3; or (ii) by U.S. 

Government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: October 1, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–23039 Filed 10–4–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0014] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Revision of a 

Previously Approved Collection; 

Application for Registration and 

Application for Registration Renewal; 

DEA Forms 224, 224A 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Drug Enforcement 

Administration (DEA), Department of 

Justice (DOJ), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until 

December 6, 2024. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Heather E. Achbach, Regulatory Drafting 

and Policy Support Section, Drug 

Enforcement Administration; Mailing 

Address: 8701 Morrissette Drive, 

Springfield, Virginia 22152; Telephone: 

(571) 776–3882; Email: DEA.PRA@

dea.gov or Heather.E.Achbach@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Bureau of Justice 

Statistics, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Abstract: The Controlled Substances 

Act (CSA) (21 U.S.C. 801–971) requires 

all persons that manufacture, distribute, 

dispense, conduct research with, 

import, or export any controlled 

substance to obtain a registration issued 

by the Attorney General. DEA would be 

revising the proposed information 

collection instruments as statutorily 

mandated by the Protecting Patient 

Access to Emergency Medications Act of 

2017. DEA would be creating a new 

business activity and adding it to forms 

DEA–224 and DEA–224A to allow 

Emergency Medical Services agencies to 

register as such, if authorized by state 

law. This new business activity would 

allow EMS agencies to obtain a DEA 

registration that will permit EMS 

agencies to deliver controlled 

substances to their designated locations 

without obtaining a separate registration 

as a Distributor. This registration would 

allow EMS personnel to administer 

controlled substances outside the 

physical presence of a medical director 

or authorizing medical professional in 

the course of providing emergency 

medical services. Upon issuance of an 

EMS agency registration, the EMS 

agency should use the online system to 

identify all of the locations it intends to 

designate under the EMS agencies’ DEA 

registration. This proposed collection 

would also allow EMS agencies to 

choose the option of a single registration 

in each state where the EMS agency 

operates. If the agency operates EMS 

facilities in multiple states, the agency 

must have a separate registration in each 

state where the agency operates. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Revision of a currently approved 

collection. 

2. The Title of the Form/Collection: 

Application for Registration and 

Application for Registration Renewal. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

DEA Forms: 224, 224A. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Diversion Control 

Division. 

4. Affected public who will be asked 

or required to respond, as well as the 

obligation to respond: Affected Public: 

(Primary) Business or other for-profit. 

Affected public (Other): Not-for-profit 

institutions; Federal, State, local, and 

tribal governments. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The DEA estimates that 

146,285 registrants participate in this 

information collection for DEA Form 

224, and 524,196 registrants for DEA 

form 224A. The time per response is 20 

minutes for DEA Form 224, and 10 

minutes for DEA Form 224A. 

6. An estimate of the total annual 

burden (in hours) associated with the 

collection: DEA estimates that this 

collection takes 48,762 annual burden 

hours for DEA Form 224 and 87,366 

annual burden hours for DEA Form 

224A. 

7. An estimate of the total annual cost 

burden associated with the collection, if 

applicable: $0. 


lotter on DSK11XQN23PROD with NOTICES1
81110 Federal Register / Vol. 89, No. 194 / Monday, October 7, 2024 / Notices 

TOTAL BURDEN HOURS

Activity Number of 

respondents 

Total annual 

responses 

Time per response 

(hours) 

Total annual 

burden 

(hours) 

DEA—224 ....................................................... 146,285 ........................ 0.33 hours (20 minutes) ................................. 48,762 

DEA—224A ..................................................... 524,196 ........................ 0.17 hours (10 minutes) ................................. 87,366 

Unduplicated Totals ................................. 670,481 ........................ ......................................................................... 136,366 

If additional information is required 

contact: Darwin Arceo, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 4W–218, 

Washington, DC 20530. 

Dated: October 1, 2024. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2024–23027 Filed 10–4–24; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0060] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; New 

Information Collection Request; 

Emergency Medical Services 

Recordkeeping and Notice 

Requirements 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Drug Enforcement 

Administration (DEA), Department of 

Justice (DOJ), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until 

December 6, 2024. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Heather E. Achbach, Regulatory Drafting 

and Policy Support Section, Drug 

Enforcement Administration; Mailing 

Address: 8701 Morrissette Drive, 

Springfield, Virginia 22152; Telephone: 

(571) 776–3882; Email: DEA.PRA@

dea.gov or Heather.E.Achbach@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Bureau of Justice 

Statistics, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Abstract: The Controlled Substances 

Act (CSA) (21 U.S.C. 801–971) requires 

all persons who handle controlled 

substances to obtain a registration from 

the Attorney General. 21 U.S.C. 822, 

823, 831, 957, and 958. The ‘‘Protecting 

Patient Access to Emergency 

Medications Act of 2017,’’ (hereafter the 

‘‘Act’’) which became law on November 

17, 2017, amended the Controlled 

Substances Act to allow for a new 

registration category for emergency 

medical services agencies that handle 

controlled substances. It also 

established standards for registering 

emergency medical services agencies, 

and set forth new requirements for 

delivery, storage, and recordkeeping 

related to their handling of controlled 

substances. 

With this proposed collection, DEA is 

proposing recordkeeping regulations for 

EMS agencies to incorporate the Act’s 

CSA amendments regarding 

recordkeeping, and to ensure an 

accurate accounting of the controlled 

substances outside the two-registrant 

integrity system. 

The Act require EMS agencies to 

maintain records of the EMS personnel 

whose State license or certification gives 

them the ability to administer controlled 

substances, in compliance with their 

State laws. Under 21 U.S.C 827(b), 

controlled substance records for all DEA 

registrants are required to be maintained 

for at least two years from the date of 

such inventory or records. Following 

the Act, 21 U.S.C. 823(k)(9)(B)(ii), DEA 

would require that records be 

maintained, whether electronically or 

otherwise, at each registered and 

designated location of the agency where 

the controlled substances involved are 

received, administered, or otherwise 

disposed of. 

Consistent with the Act’s 

amendments to the CSA, 21 U.S.C. 

823(k)(9), DEA would require an EMS 

agency to maintain records for each 

controlled substance administered or 

disposed of in the course of providing 

emergency medical services. In 

addition, any EMS personnel who 

disposes of or administers controlled 

substances to a patient in the course of 

providing emergency medical care 

would have to record the name of the 

controlled substance(s) and detailed 

information about the circumstances 

surrounding the administration of the 

controlled substance(s) (e.g., name of 

the substance, date dispensed, 

identification of the patient). 

Additionally, in accordance with 21 

U.S.C 821(k)(9)(b), that an EMS agency 

must maintain records of controlled 

substances delivered between registered 

and designated locations of the agency 

(except agencies restocking at the 

hospital under which the EMS agency is 

operating, because the hospital is 

required to keep records of such 

restocking). These records, for example, 

should include the name of the 

controlled substance(s), finished form, 

number of units in the commercial 

container, date delivered, and the 

address of the EMS agency location 

where the controlled substances were 

delivered. 


lotter on DSK11XQN23PROD with NOTICES1